Meda in brief

Meda is an international specialty pharma company with its own sales organizations in over 50 countries and operations expanding in growth markets. Meda has total coverage of about 75% of the global pharmaceutical
market.

Meda's pharmaceuticals are available in more than 120 countries, and Meda is about the 50th largest pharmaceutical company in the world by sales. In 2011, sales reached SEK 12,856 million.

Meda's well-diversified product portfolio is divided into three segments: Specialty Products, Branded Generics and OTC. Meda focuses mainly on five key therapy areas: respiratory, cardiology, pain and inflammation, dermatology, and CNS.

 

 

Print E-mail this page
  • Meda in brief
  • Sales and Marketing
  • Business Development
  • Drug Development
  • Regulatory Affairs
  • Manufacture and Product Supply
  • Board of Directors
  • Senior Executives
  • About Meda
  • Product Portfolio
  • Financial information
  • News
  • Corporate Governance
  • CSR
  • Contact us
  • Sitemap »
  • Swedish | 
  • English
Meda Worldwide
  • Sweden
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lituania
  • Latvia
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Serbia
  • Slovakia
  • Spain
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • USA

Meda AB
Box 906
SE-170 09 Solna
Sweden

Visitors: Pipers väg 2A
Tel: +46 8-630 19 00
Fax: +46 8-630 19 50
E-mail: info@meda.se

  • Contact »
  • Terms of Use »
  • Privacy Policy »
  • Cookies »
  • Copyright Meda »